Explore 3 Stock Ideas & Industry Insights Download Free Report

ALR Technologies Inc.

Company price
0.0155 USD 0.00 ( 10.71%)
Last update at 2026-11-20T15:14:00Z
VOLUME
10607
Market Cap
10.97M

Momentum Score

…

ALR Technologies SG Ltd., a data management company, provides diabetes care management solutions. It offers ALRT Diabetes Solution, a diabetes care that includes a diabetes management system that collects data directly from blood glucose meters and continuous glucose monitoring devices, and Predictive A1C algorithm to track treatment success between lab reports and an FDA-cleared Insulin Dosing Adjustment program. The company also provides GluCurve Pet CGM, a solution to address an unmet need in diabetes care for felines and canines by combining the hardware of a CGM with the software of an adapted version of diabetes solution product for use by veterinarians in animal health. In addition, it offers healthcare services, including medical clinics, hospitals, and health plans, and veterinary clinics with diabetics being the initial patient targets. The company sells its products directly and through distributors in the United States, Brazil, the United Kingdom, European Union, and internationally. The company was incorporated in 1987 and is based in Singapore.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.02
Low
0.02
High
52 Week Price Range
0.01
Low
0.03
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Public information on ALR Technologies Inc. (ALRTF) is limited and its core business activities and long-term growth drivers are not clearly documented in accessible filings or on a company website. Investors may be attracted by potential upside common to thinly traded PINK-listed issuers, but should monitor company disclosures and operational updates for substantiation.
Primary investment risks include limited disclosure and financial transparency, low liquidity, and elevated execution and financing risk typical of OTC Pink-listed microcap companies.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.01
Dividend Yield
-
Revenue TTM
0.03M
Revenue Per Share
-
Gross Profit TTM
0.00M
Debt / Equity
-
ROE
-
Net Debt
32.26M
ROCE
7.23%
Diluted EPS TTM
-0.04

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -22.06M -15.88M -7.48M -10.62M -8.44M
Net income -22.06M -15.88M -7.47M -10.62M -8.44M
Selling general administrative 2.09M 2.62M 3.37M 3.73M 5.84M
Gross profit 0.00M 0.00M 0.00M 0.00M 0.00M
Ebit - - - - -2.94M
Ebitda - - - - -6.40M
Operating income -2.88M -3.50M -4.77M -4.21M -6.33M
Interest expense 19.74M 12.42M 2.52M 6.35M 2.04M
Net interest income -19.74M -12.42M -2.52M -6.35M -2.04M
Total revenue 0.00M 0.00M 0.03M 0.00M 0.01M
Total operating expenses 2.88M 3.50M 4.80M 4.21M 6.34M
Cost of revenue 0.00M 0.00M 0.02M 0.00M 0.00M
Total other income expense net 0.56M 0.05M -0.18M -0.06M -0.07M
Net income from continuing ops -22.06M -15.88M -7.48M -10.62M -8.44M
Net income applicable to common shares - - - - -8.44M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 0.05M 0.08M 0.16M 0.38M 0.19M
Total liab 39.91M 36.30M 32.07M 28.93M 24.51M
Total stockholder equity -39.86M -36.22M -31.92M -28.55M -24.31M
Other current liab - - - - 0.00M
Common stock - - - - 0.54M
Capital stock 31.49M 31.29M 30.91M 28.04M 0.54M
Retained earnings -158.04M -135.99M -120.11M -112.63M -102.02M
Cash 0.02M 0.04M 0.06M 0.15M 0.12M
Total current liabilities 39.91M 36.30M 32.07M 27.09M 24.51M
Net debt 32.26M 28.58M 25.34M 22.78M 19.15M
Short long term debt 32.28M 28.62M 25.40M 21.08M 19.26M
Other stockholder equity - - - - -0.01M
Total current assets 0.05M 0.08M 0.16M 0.38M 0.19M
Net tangible assets - - - - -24.31M
Net receivables - 0.00M 0.04M 0.00M -
Long term debt - - - 1.84M -
Inventory 0.01M 0.01M 0.01M 0.00M -
Accounts payable 1.29M 1.68M 1.18M 1.05M 0.81M
Non current assets total 0.00M 0.00M 0.00M 0.00M 0.00M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Change to liabilities - - - - 0.21M
Net borrowings 1.85M 1.52M 0.79M 2.51M 0.69M
Total cash from financing activities 1.85M 1.52M 1.54M 2.51M 1.83M
Change to operating activities - - - - 0.51M
Net income -22.06M -15.88M -7.47M -10.62M -8.44M
Change in cash -0.02M -0.02M -0.09M 0.03M 0.05M
Begin period cash flow 0.04M 0.06M 0.15M 0.12M 0.07M
End period cash flow 0.02M 0.04M 0.06M 0.15M 0.12M
Total cash from operating activities -1.87M -1.54M -1.62M -2.57M -1.77M
Issuance of capital stock 0.00M 0.00M 0.74M 0.00M 1.14M
Dividends paid - - - 0.00M 0.00M
Change to inventory 0.00M 0.00M -0.01M 0.00M -
Change to account receivables 0.00M 0.00M -0.04M 0.00M -
Change to netincome - - - - 5.95M
Capital expenditures 0.00M 0.00M 0.00M 0.00M 0.00M
Change in working capital 0.88M 1.03M 1.13M 0.73M 0.72M
Stock based compensation 18.27M 11.53M 2.87M 5.77M 4.40M
Other non cash items 1.10M 2.07M 1.99M 2.04M 1.51M
Free cash flow -1.87M -1.54M -1.62M -2.57M -1.77M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
ALRTF
ALR Technologies Inc.
0.00
10.71%
0.02 - 29.67 364.05 - 1388.64 -6.88
ABT
Abbott Laboratories
-0.20
0.19%
103.00 25.97 17.24 3.57 3.20 3.81 16.75
MDT
Medtronic PLC
-0.59
0.59%
100.02 26.60 15.87 3.35 2.08 3.90 14.12
SYK
Stryker Corporation
-
-%
310.00 29.23 16.86 4.18 4.51 4.63 17.16
SEMHF
Siemens Healthineers AG
-
-%
48.34 39.57 21.32 3.01 3.29 2.95 16.92

Profile*

ALR Technologies Inc.

ALR Technologies SG Ltd., a data management company, provides diabetes care management solutions. It offers ALRT Diabetes Solution, a diabetes care that includes a diabetes management system that collects data directly from blood glucose meters and continuous glucose monitoring devices, and Predictive A1C algorithm to track treatment success between lab reports and an FDA-cleared Insulin Dosing Adjustment program. The company also provides GluCurve Pet CGM, a solution to address an unmet need in diabetes care for felines and canines by combining the hardware of a CGM with the software of an adapted version of diabetes solution product for use by veterinarians in animal health. In addition, it offers healthcare services, including medical clinics, hospitals, and health plans, and veterinary clinics with diabetics being the initial patient targets. The company sells its products directly and through distributors in the United States, Brazil, the United Kingdom, European Union, and internationally. The company was incorporated in 1987 and is based in Singapore.

9 Raffles Place, Singapore, Singapore, 048619

65 3129 2924

7

Name Title Year Born
Mr. Sidney S. Chan Chairman, CEO, CFO, Principal Accounting Officer, Treasurer & Sec. 1950
Mr. Steven Brassard C.A., CPA, CA, CPA Director of Fin., Accounting & Admin. 1986
Ms. Jacqueline Wu Head of Corp. Marketing NA
Mr. Joe Stern Head of Animal Health NA
Dr. James R. Raphael Gavin III, M.D., Ph.D. Sr. Medical Consultant 1946
Ms. Barbara Dubiel Consultant NA
Mr. Barrett D. Ehrlich Consultant NA
Mr. Mark Geoffrey Uy Consultant NA
Mr. Johnny Tlardera Consultant NA
Mr. John Lester Tolentino Consultant NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…